Ian M. Baird
- Epidemiology
- Infectious Diseases top 10%
- Pharmacology
- Clinical Biochemistry top 10%
- Molecular Medicine top 10%
- Co-authors
- Chatrchai WatanakunakornJoseph F. PlouffeGuy W. AmsdenStuart H. SimonO G DodgeRobert FeketyD. H. BattsGary D. Rifkin
- Topics
- Antibiotic Resistance in Bacteria (4 papers)Antimicrobial Resistance in Staphylococcus (4 papers)Pneumonia and Respiratory Infections (3 papers)
- Partner nations
- United StatesUnited KingdomPuerto Rico
In The Last Decade
Ian M. Baird
18 papers receiving 356 citations
Peers
Comparison fields: 5 of 60
- Epidemiology 235
- Infectious Diseases 166
- Pharmacology 81
- Clinical Biochemistry 65
- Molecular Medicine 62
Countries citing papers authored by Ian M. Baird
This map shows the geographic impact of Ian M. Baird's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ian M. Baird with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ian M. Baird more than expected).
Fields of papers citing papers by Ian M. Baird
This network shows the impact of papers produced by Ian M. Baird. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ian M. Baird. The network helps show where Ian M. Baird may publish in the future.
Co-authorship network of co-authors of Ian M. Baird
This figure shows the co-authorship network connecting the top 25 collaborators of Ian M. Baird. A scholar is included among the top collaborators of Ian M. Baird based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ian M. Baird. Ian M. Baird is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 46 | |
| 2 | An open-label trial of stavudine, lamivudine and efavirenz in the treatment of HIV-positive, treatment-naive patients, and implications for clinical practice. | 1 |
| 3 | Liposomal nystatin (LNY) vs. amphotericin B (AMB) for Candidemia in non-neutropenic patients: A historical comparison | 2 |
| 4 | 54 | |
| 5 | 7 | |
| 6 | 15 | |
| 7 | 6 | |
| 8 | 2 | |
| 9 | 2 | |
| 10 | 60 | |
| 11 | 20 | |
| 12 | 75 | |
| 13 | 73 | |
| 14 | 12 | |
| 15 | 10 | |
| 16 | 2 | |
| 17 | 2 | |
| 18 | 20 |
About Ian M. Baird
Ian M. Baird is a scholar working on Applied Microbiology and Biotechnology, Molecular Medicine and Critical Care and Intensive Care Medicine, having authored 18 papers that have together received 409 indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (4 papers), Antimicrobial Resistance in Staphylococcus (4 papers) and Pneumonia and Respiratory Infections (3 papers). The work is most often cited by research in Molecular Medicine (62 citations), Clinical Biochemistry (65 citations) and Infectious Diseases (166 citations). Ian M. Baird has collaborated with scholars based in United States, United Kingdom and Puerto Rico. Frequent co-authors include Chatrchai Watanakunakorn, Joseph F. Plouffe, Guy W. Amsden, Stuart H. Simon, O G Dodge, Robert Fekety, D. H. Batts, Gary D. Rifkin, Thomas M. File and James B. Kahn. Their work appears in journals such as Clinical Infectious Diseases, Gut and CHEST Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.